DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
CO-ZIDOCAPT
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CO-ZIDOCAPT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C16H23ClN4O7S3
Molecular Weight:
515.04
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
METHYLPYRROLIDONE
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
METHYLPYRROLIDONE
×
Maximum Phase:
1
First Approval:
None
UNII:
JR9CE63FPM
Molecule Type:
Small molecule
Molecular Formula:
C5H9NO
Molecular Weight:
99.13
AlogP:
0.24
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
0.0
Source:
ASTAXANTHIN
1
Small molecule
Investigational
Unknown
Unknown
Metabolic Syndrome; Diabetic Neuropathies
Unknown
ASTAXANTHIN
×
Maximum Phase:
1
First Approval:
None
UNII:
8XPW32PR7I
Molecule Type:
Small molecule
Molecular Formula:
C40H52O4
Molecular Weight:
596.85
AlogP:
8.91
PSA:
74.6
HBD:
2.0
HBA:
#RotB:
10.0
Source:
BIIF 1149 BS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BIIF 1149 BS
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
L-377202
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
L-377202
×
Maximum Phase:
1
First Approval:
None
UNII:
VDXVABRQTV
Molecule Type:
Small molecule
Molecular Formula:
C65H89N9O25
Molecular Weight:
1396.46
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
XL-019
1
Small molecule
Investigational
Unknown
Unknown
Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential
Tyrosine-protein kinase JAK2 inhibitor
XL-019
×
Maximum Phase:
1
First Approval:
None
UNII:
4L1AM42NVA
Molecule Type:
Small molecule
Molecular Formula:
C25H28N6O2
Molecular Weight:
444.54
AlogP:
3.41
PSA:
91.41
HBD:
3.0
HBA:
#RotB:
6.0
Source:
PKI-166
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
PKI-166
×
Maximum Phase:
1
First Approval:
None
UNII:
9RIE5HW38P
Molecule Type:
Small molecule
Molecular Formula:
C20H18N4O
Molecular Weight:
330.39
AlogP:
4.5
PSA:
73.83
HBD:
3.0
HBA:
#RotB:
4.0
Source:
CI-988
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cholecystokinin B receptor antagonist
CI-988
×
Maximum Phase:
1
First Approval:
None
UNII:
2637PDX9SI
Molecule Type:
Small molecule
Molecular Formula:
C35H42N4O6
Molecular Weight:
614.74
AlogP:
4.86
PSA:
149.62
HBD:
5.0
HBA:
#RotB:
12.0
Source:
LY-2334737
1
Small molecule
Investigational
Unknown
Unknown
Neoplasm Metastasis; Neoplasms
Unknown
LY-2334737
×
Maximum Phase:
1
First Approval:
None
UNII:
YLR364XYSA
Molecule Type:
Small molecule
Molecular Formula:
C17H25F2N3O5
Molecular Weight:
389.4
AlogP:
1.28
PSA:
113.68
HBD:
3.0
HBA:
#RotB:
8.0
Source:
SETANAXIB
1
Small molecule
Investigational
Unknown
Unknown
Idiopathic Pulmonary Fibrosis; Liver Cirrhosis, Biliary
Unknown
SETANAXIB
×
Maximum Phase:
1
First Approval:
None
UNII:
45II35329V
Molecule Type:
Small molecule
Molecular Formula:
C21H19ClN4O2
Molecular Weight:
394.86
AlogP:
3.4
PSA:
63.03
HBD:
1.0
HBA:
#RotB:
3.0
Source:
TAS-115
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Hepatocyte growth factor receptor inhibitor
TAS-115
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PBF-999
1
Small molecule
Investigational
Unknown
Unknown
Huntington Disease; Neoplasms
Adenosine A2a receptor antagonist
PBF-999
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CITARINOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Melanoma; Multiple Myeloma; Neoplasms
Unknown
CITARINOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
441P620G3P
Molecule Type:
Small molecule
Molecular Formula:
C24H26ClN5O3
Molecular Weight:
467.96
AlogP:
4.79
PSA:
107.45
HBD:
3.0
HBA:
#RotB:
11.0
Source:
D-FLUOROMETHYLTYROSINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D-FLUOROMETHYLTYROSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
GSM7N3U4J8
Molecule Type:
Small molecule
Molecular Formula:
C10H12FNO3
Molecular Weight:
213.21
AlogP:
0.95
PSA:
72.55
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CEP-7055
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vascular endothelial growth factor receptor inhibitor
CEP-7055
×
Maximum Phase:
1
First Approval:
None
UNII:
AD6CBG7OXO
Molecule Type:
Small molecule
Molecular Formula:
C32H35N3O4
Molecular Weight:
525.65
AlogP:
5.03
PSA:
72.8
HBD:
1.0
HBA:
#RotB:
9.0
Source:
WX-037
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
PI3-kinase class I inhibitor
WX-037
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CFG-920
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CFG-920
×
Maximum Phase:
1
First Approval:
None
UNII:
UP0K5026VB
Molecule Type:
Small molecule
Molecular Formula:
C14H13ClN4O
Molecular Weight:
288.74
AlogP:
2.89
PSA:
49.33
HBD:
0.0
HBA:
#RotB:
2.0
Source:
BMS-908662
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-908662
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BALAMAPIMOD
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
BALAMAPIMOD
×
Maximum Phase:
1
First Approval:
None
UNII:
7Y0IV7N95Q
Molecule Type:
Small molecule
Molecular Formula:
C30H32ClN7OS
Molecular Weight:
574.15
AlogP:
6.46
PSA:
82.24
HBD:
1.0
HBA:
#RotB:
7.0
Source:
TBA-354
1
Small molecule
Investigational
Unknown
Unknown
Tuberculosis
Unknown
TBA-354
×
Maximum Phase:
1
First Approval:
None
UNII:
911T37M2WY
Molecule Type:
Small molecule
Molecular Formula:
C19H15F3N4O5
Molecular Weight:
436.35
AlogP:
3.73
PSA:
101.54
HBD:
0.0
HBA:
#RotB:
6.0
Source:
IRAMPANEL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Glutamate receptor ionotropic AMPA antagonist
IRAMPANEL
×
Maximum Phase:
1
First Approval:
None
UNII:
R2GZD7LMYX
Molecule Type:
Small molecule
Molecular Formula:
C18H19N3O2
Molecular Weight:
309.37
AlogP:
3.34
PSA:
51.39
HBD:
0.0
HBA:
#RotB:
6.0
Source:
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
MK-8245
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
MK-8245
×
Maximum Phase:
1
First Approval:
None
UNII:
537E7QE8LX
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrFN6O4
Molecular Weight:
467.26
AlogP:
2.36
PSA:
119.4
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CLX-0921
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Peroxisome proliferator-activated receptor gamma agonist
CLX-0921
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CORT125281
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CORT125281
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SALVIANOLIC ACID A
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus; Diabetic Neuropathies
Unknown
SALVIANOLIC ACID A
×
Maximum Phase:
1
First Approval:
None
UNII:
51622542XO
Molecule Type:
Small molecule
Molecular Formula:
C26H22O10
Molecular Weight:
494.45
AlogP:
3.34
PSA:
184.98
HBD:
7.0
HBA:
#RotB:
8.0
Source:
AZD-7295
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis C
Unknown
AZD-7295
×
Maximum Phase:
1
First Approval:
None
UNII:
102MC1467J
Molecule Type:
Small molecule
Molecular Formula:
C32H35F3N4O5S
Molecular Weight:
644.72
AlogP:
5.71
PSA:
108.05
HBD:
2.0
HBA:
#RotB:
11.0
Source:
ANSOFAXINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ANSOFAXINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
5-AMINOVALERIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
5-AMINOVALERIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C5H11NO2
Molecular Weight:
117.15
AlogP:
0.2
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
4.0
Source:
CH5132799
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CH5132799
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACT-462206
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ACT-462206
×
Maximum Phase:
1
First Approval:
None
UNII:
64ONO62P28
Molecule Type:
Small molecule
Molecular Formula:
C20H24N2O4S
Molecular Weight:
388.49
AlogP:
3.1
PSA:
75.71
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PF-114
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Unknown
PF-114
×
Maximum Phase:
1
First Approval:
None
UNII:
I8C3R768IZ
Molecule Type:
Small molecule
Molecular Formula:
C29H27F3N6O
Molecular Weight:
532.57
AlogP:
4.46
PSA:
65.77
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DIINDOLYLMETHANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DIINDOLYLMETHANE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
L-FUCOSE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
L-FUCOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
28RYY2IV3F
Molecule Type:
Small molecule
Molecular Formula:
C6H12O5
Molecular Weight:
164.16
AlogP:
-2.19
PSA:
90.15
HBD:
4.0
HBA:
#RotB:
0.0
Source:
LETRAZURIL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LETRAZURIL
×
Maximum Phase:
1
First Approval:
None
UNII:
U8736VCB22
Molecule Type:
Small molecule
Molecular Formula:
C17H9Cl2FN4O2
Molecular Weight:
391.19
AlogP:
3.02
PSA:
91.54
HBD:
1.0
HBA:
#RotB:
3.0
Source:
1
2
…
77
78
79
80
81
82
83
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA